FDA approves Android-based blood glucose monitor
December 15, 2015
The US Food and Drug Administration (FDA) has approved clearance for the Gmate Smart blood glucose monitoring system and app for Android from Korean company Philosys. This diabetes management technology is for use on smartphones
The Gmate Smart is a small, portable blood glucose meter that plugs into the headphone jack of a smartphone and provides fast and accurate blood glucose test results. Together, the meter and app turn a smartphone into a mobile blood glucose monitoring system. The app is now available for both iOS and Android users.
The meter is the size of a small coin and connects to the headphone jack of the smartphone. The app integrates directly to the iOS and Android device, providing diabetes management including goal setting, graphing and the ability to email or text blood glucose test results directly to a family member or healthcare provider.
The app stores an unlimited number of test results electronically with the date and time. A user can also add custom comments, actions or notes to each test result. This is said to be a faster, smarter way to manage and improve diabetes care. The app is a free download on the App Store and Google Play.
"As cloud technology grows, Philosys is working to create an app-to-cloud secure connection in the next generation of updates,” said Mike Tickle, senior VP of sales. "This will allow for improved communications and notifications between patients and physicians. The Gmate Smart app can provide appropriate automated responses as determined by the medical team. Not only is Gmate Smart changing diabetes care by improving health and lifestyle, but it's also affordable. Most retail pharmacies are selling both the meter and box of 50 count strips at a low cost."
Philosys is a manufacturing company that specialises in medical, diagnostics and analytical instruments. The range of services provided covers the entire product cycle from concept through to manufacture.